The digital pathology slide scanner market size has grown rapidly in recent years. It will grow from $1.04 billion in 2025 to $1.16 billion in 2026 at a compound annual growth rate (CAGR) of 11.6%. The growth in the historic period can be attributed to dependency on manual microscopy-based diagnosis, limited storage and archival capacity for glass slides, low scanner resolution and high equipment costs, slow adoption of digital laboratory systems, and shortage of skilled pathology workforce in remote regions.
The digital pathology slide scanner market size is expected to see rapid growth in the next few years. It will grow to $1.82 billion in 2030 at a compound annual growth rate (CAGR) of 11.8%. The growth in the forecast period can be attributed to rising adoption of telepathology, increasing demand for precision medicine diagnostics, expansion of hospital laboratory automation, growing need for data-driven diagnostic workflows, and increasing investment in cancer diagnostics infrastructure. Major trends in the forecast period include increasing adoption of remote pathology collaboration networks, rising demand for standardized digital slide archiving and retention compliance, expansion of high-throughput screening workflows in clinical pathology labs, growing emphasis on regulatory compliance and quality assurance in digital diagnostics, and increasing investment in ergonomic and user-friendly slide scanner hardware design.
The rising prevalence of cardiovascular diseases is expected to drive the growth of the digital pathology slide scanner market in the coming years. Cardiovascular diseases are disorders that affect the heart and blood vessels, including conditions such as coronary heart disease, stroke, heart failure, and arrhythmias. The increasing prevalence of cardiovascular diseases is being driven by aging populations, as advancing age significantly raises the risk of developing heart and vascular conditions, particularly among individuals over 65 years. Digital pathology slide scanners enable high-resolution digitization and analysis of tissue samples, supporting the detection of microscopic vascular and cardiac abnormalities with greater accuracy and improving diagnosis and research in cardiovascular diseases. For example, in October 2024, according to the Centers for Disease Control and Prevention, a US-based government agency, cardiovascular disease accounted for 919,032 deaths in 2023, representing about one-third of all deaths. Coronary heart disease remained the most common type, with nearly one in six cardiovascular deaths occurring in adults under 65 years of age. Therefore, the rising prevalence of cardiovascular diseases is contributing to the growth of the digital pathology slide scanner market.
Major companies operating in the digital pathology slide scanner market are focusing on the development of advanced solutions such as whole-slide imaging systems to improve diagnostic accuracy, enable rapid high-resolution tissue analysis, and facilitate efficient digital workflow integration in pathology laboratories. Whole-slide imaging systems are digital pathology technologies that scan complete microscope slides at high resolution to generate detailed, navigable digital images for remote viewing, analysis, and diagnosis. For instance, in September 2024, Vieworks Co., Ltd., a South Korea-based bioimaging solutions company, introduced the LUCEON 510, an advanced digital pathology slide scanner. This system features a unique three-camera configuration that captures multiple focal plane images simultaneously, enabling four distinct imaging modes optimized for histopathology and cytology applications. The system delivers high-speed scanning performance while maintaining data efficiency comparable to single-camera systems, thereby improving workflow productivity and image accuracy. Additionally, it supports a wide range of sample types and enhances diagnostic precision through advanced imaging capabilities, making it suitable for both clinical and research settings.
In August 2025, Evident Corporation, a Japan-based medical imaging and life sciences company, acquired Pramana Inc. for an undisclosed amount. Through this acquisition, Evident aims to enhance its digital pathology capabilities by integrating Pramana’s autonomous whole-slide imaging (WSI) technologies and AI-powered scanning systems, strengthening its digital pathology slide scanner portfolio and enabling high-throughput slide digitization, workflow automation, and advanced diagnostic imaging. Pramana Inc. is a US-based healthcare technology company specializing in fully autonomous digital pathology slide scanners and AI-enabled imaging systems used across hospitals, research laboratories, and academic institutions.
Major companies operating in the digital pathology slide scanner market are F. Hoffmann-La Roche AG, Danaher Corporation, Koninklijke Philips N.V., Evident Corporation, Nikon Corporation, Carl Zeiss AG, Hamamatsu Photonics K.K., Motic China Group Co. Ltd., OptraSCAN Inc., Morphle Labs Inc., Scopio Labs Ltd., 3DHISTECH Ltd., Vieworks Co Ltd, PreciPoint Group GmbH, Hangzhou KFBIO Biotechnology Co. Ltd., Huron Digital Pathology Inc., Mikroscan Technologies Inc., Paige.AI, Proscia Inc., Sectra AB, Indica Labs, Visiopharm.
North America was the dominant region in the digital pathology slide scanner market in 2025. Europe is expected to be the rapidly expanding region in the forecast period. The regions covered in digital pathology slide scanner report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the digital pathology slide scanner market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The digital pathology slide scanner market consists of revenues earned by entities by providing services such as whole slide imaging services, telepathology consultations, digital slide storage and management, and scanner maintenance and support services. The market value includes the value of related goods sold by the service provider or included within the service offering. The digital pathology slide scanner market also includes sales of whole slide imaging systems, automated slide scanners, image analysis software platforms, and digital pathology storage and management systems. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
The digital pathology slide scanner market research report is one of a series of new reports that provides digital pathology slide scanner market statistics, including digital pathology slide scanner industry global market size, regional shares, competitors with a digital pathology slide scanner market share, detailed digital pathology slide scanner market segments, market trends and opportunities, and any further data you may need to thrive in the digital pathology slide scanner industry. This digital pathology slide scanner market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
This product will be delivered within 1-3 business days.
The digital pathology slide scanner market size is expected to see rapid growth in the next few years. It will grow to $1.82 billion in 2030 at a compound annual growth rate (CAGR) of 11.8%. The growth in the forecast period can be attributed to rising adoption of telepathology, increasing demand for precision medicine diagnostics, expansion of hospital laboratory automation, growing need for data-driven diagnostic workflows, and increasing investment in cancer diagnostics infrastructure. Major trends in the forecast period include increasing adoption of remote pathology collaboration networks, rising demand for standardized digital slide archiving and retention compliance, expansion of high-throughput screening workflows in clinical pathology labs, growing emphasis on regulatory compliance and quality assurance in digital diagnostics, and increasing investment in ergonomic and user-friendly slide scanner hardware design.
The rising prevalence of cardiovascular diseases is expected to drive the growth of the digital pathology slide scanner market in the coming years. Cardiovascular diseases are disorders that affect the heart and blood vessels, including conditions such as coronary heart disease, stroke, heart failure, and arrhythmias. The increasing prevalence of cardiovascular diseases is being driven by aging populations, as advancing age significantly raises the risk of developing heart and vascular conditions, particularly among individuals over 65 years. Digital pathology slide scanners enable high-resolution digitization and analysis of tissue samples, supporting the detection of microscopic vascular and cardiac abnormalities with greater accuracy and improving diagnosis and research in cardiovascular diseases. For example, in October 2024, according to the Centers for Disease Control and Prevention, a US-based government agency, cardiovascular disease accounted for 919,032 deaths in 2023, representing about one-third of all deaths. Coronary heart disease remained the most common type, with nearly one in six cardiovascular deaths occurring in adults under 65 years of age. Therefore, the rising prevalence of cardiovascular diseases is contributing to the growth of the digital pathology slide scanner market.
Major companies operating in the digital pathology slide scanner market are focusing on the development of advanced solutions such as whole-slide imaging systems to improve diagnostic accuracy, enable rapid high-resolution tissue analysis, and facilitate efficient digital workflow integration in pathology laboratories. Whole-slide imaging systems are digital pathology technologies that scan complete microscope slides at high resolution to generate detailed, navigable digital images for remote viewing, analysis, and diagnosis. For instance, in September 2024, Vieworks Co., Ltd., a South Korea-based bioimaging solutions company, introduced the LUCEON 510, an advanced digital pathology slide scanner. This system features a unique three-camera configuration that captures multiple focal plane images simultaneously, enabling four distinct imaging modes optimized for histopathology and cytology applications. The system delivers high-speed scanning performance while maintaining data efficiency comparable to single-camera systems, thereby improving workflow productivity and image accuracy. Additionally, it supports a wide range of sample types and enhances diagnostic precision through advanced imaging capabilities, making it suitable for both clinical and research settings.
In August 2025, Evident Corporation, a Japan-based medical imaging and life sciences company, acquired Pramana Inc. for an undisclosed amount. Through this acquisition, Evident aims to enhance its digital pathology capabilities by integrating Pramana’s autonomous whole-slide imaging (WSI) technologies and AI-powered scanning systems, strengthening its digital pathology slide scanner portfolio and enabling high-throughput slide digitization, workflow automation, and advanced diagnostic imaging. Pramana Inc. is a US-based healthcare technology company specializing in fully autonomous digital pathology slide scanners and AI-enabled imaging systems used across hospitals, research laboratories, and academic institutions.
Major companies operating in the digital pathology slide scanner market are F. Hoffmann-La Roche AG, Danaher Corporation, Koninklijke Philips N.V., Evident Corporation, Nikon Corporation, Carl Zeiss AG, Hamamatsu Photonics K.K., Motic China Group Co. Ltd., OptraSCAN Inc., Morphle Labs Inc., Scopio Labs Ltd., 3DHISTECH Ltd., Vieworks Co Ltd, PreciPoint Group GmbH, Hangzhou KFBIO Biotechnology Co. Ltd., Huron Digital Pathology Inc., Mikroscan Technologies Inc., Paige.AI, Proscia Inc., Sectra AB, Indica Labs, Visiopharm.
North America was the dominant region in the digital pathology slide scanner market in 2025. Europe is expected to be the rapidly expanding region in the forecast period. The regions covered in digital pathology slide scanner report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the digital pathology slide scanner market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The digital pathology slide scanner market consists of revenues earned by entities by providing services such as whole slide imaging services, telepathology consultations, digital slide storage and management, and scanner maintenance and support services. The market value includes the value of related goods sold by the service provider or included within the service offering. The digital pathology slide scanner market also includes sales of whole slide imaging systems, automated slide scanners, image analysis software platforms, and digital pathology storage and management systems. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
The digital pathology slide scanner market research report is one of a series of new reports that provides digital pathology slide scanner market statistics, including digital pathology slide scanner industry global market size, regional shares, competitors with a digital pathology slide scanner market share, detailed digital pathology slide scanner market segments, market trends and opportunities, and any further data you may need to thrive in the digital pathology slide scanner industry. This digital pathology slide scanner market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Digital Pathology Slide Scanner Market Characteristics
3. Digital Pathology Slide Scanner Market Supply Chain Analysis
4. Global Digital Pathology Slide Scanner Market Trends And Strategies
5. Digital Pathology Slide Scanner Market Analysis Of End Use Industries
7. Global Digital Pathology Slide Scanner Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis
8. Global Digital Pathology Slide Scanner Total Addressable Market (TAM) Analysis for the Market
9. Digital Pathology Slide Scanner Market Segmentation
10. Digital Pathology Slide Scanner Market Regional And Country Analysis
11. Asia-Pacific Digital Pathology Slide Scanner Market
12. China Digital Pathology Slide Scanner Market
13. India Digital Pathology Slide Scanner Market
14. Japan Digital Pathology Slide Scanner Market
15. Australia Digital Pathology Slide Scanner Market
16. Indonesia Digital Pathology Slide Scanner Market
17. South Korea Digital Pathology Slide Scanner Market
18. Taiwan Digital Pathology Slide Scanner Market
19. South East Asia Digital Pathology Slide Scanner Market
20. Western Europe Digital Pathology Slide Scanner Market
21. UK Digital Pathology Slide Scanner Market
22. Germany Digital Pathology Slide Scanner Market
23. France Digital Pathology Slide Scanner Market
24. Italy Digital Pathology Slide Scanner Market
25. Spain Digital Pathology Slide Scanner Market
26. Eastern Europe Digital Pathology Slide Scanner Market
27. Russia Digital Pathology Slide Scanner Market
28. North America Digital Pathology Slide Scanner Market
29. USA Digital Pathology Slide Scanner Market
30. Canada Digital Pathology Slide Scanner Market
31. South America Digital Pathology Slide Scanner Market
32. Brazil Digital Pathology Slide Scanner Market
33. Middle East Digital Pathology Slide Scanner Market
34. Africa Digital Pathology Slide Scanner Market
36. Digital Pathology Slide Scanner Market Competitive Landscape And Company Profiles
37. Digital Pathology Slide Scanner Market Other Major And Innovative Companies
41. Digital Pathology Slide Scanner Market High Potential Countries, Segments and Strategies
42. Appendix
Executive Summary
Digital Pathology Slide Scanner Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses digital pathology slide scanner market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for digital pathology slide scanner? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The digital pathology slide scanner market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product Type: Brightfield; Fluorescence; Other Product Types2) By Technology: Whole Slide Imaging; Live View Scanning; Z Stack Scanning Or Focus Stacking; Confocal Scanning; Other Technologies
3) By Slide Capacity: Low Capacity Scanners; Medium Capacity Scanners; High Capacity Scanners
4) By Application: Disease Diagnosis; Academic Research; Drug Discovery; Other Applications
5) By End User: Hospitals; Diagnostic Laboratories; Academic And Research Institutes; Pharmaceutical And Biotechnology Companies; Other End Users
Subsegments:
1) By Brightfield: Clinical Diagnostic Imaging; Histopathology Imaging; Cytology Imaging; Routine Tissue Examination Imaging; High Throughput Slide Imaging2) By Fluorescence: Immunofluorescence Imaging; Molecular Marker Imaging; Protein Expression Imaging; Cellular Structure Imaging; Multichannel Fluorescence Imaging
3) By Other Product Types: Hybrid Imaging Systems; Multimodal Imaging Systems; Spectral Imaging Systems; Advanced Contrast Imaging Systems; Specialized Research Imaging Systems
Companies Mentioned: F. Hoffmann-La Roche AG; Danaher Corporation; Koninklijke Philips N.V.; Evident Corporation; Nikon Corporation; Carl Zeiss AG; Hamamatsu Photonics K.K.; Motic China Group Co. Ltd.; OptraSCAN Inc.; Morphle Labs Inc.; Scopio Labs Ltd.; 3DHISTECH Ltd.; Vieworks Co Ltd; PreciPoint Group GmbH; Hangzhou KFBIO Biotechnology Co. Ltd.; Huron Digital Pathology Inc.; Mikroscan Technologies Inc.; Paige.AI; Proscia Inc.; Sectra AB; Indica Labs; Visiopharm.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
- F. Hoffmann-La Roche AG
- Danaher Corporation
- Koninklijke Philips N.V.
- Evident Corporation
- Nikon Corporation
- Carl Zeiss AG
- Hamamatsu Photonics K.K.
- Motic China Group Co. Ltd.
- OptraSCAN Inc.
- Morphle Labs Inc.
- Scopio Labs Ltd.
- 3DHISTECH Ltd.
- Vieworks Co Ltd
- PreciPoint Group GmbH
- Hangzhou KFBIO Biotechnology Co. Ltd.
- Huron Digital Pathology Inc.
- Mikroscan Technologies Inc.
- Paige.AI
- Proscia Inc.
- Sectra AB
- Indica Labs
- Visiopharm.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | July 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 1.16 Billion |
| Forecasted Market Value ( USD | $ 1.82 Billion |
| Compound Annual Growth Rate | 11.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 22 |
